Physiology and its importance for reference intervals

Clinical Biochemist Reviews

Volumn 35, Issue 1, 2014, Pages 3-14

  Sikaris, Kenneth A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901978686     PISSN: 01598090     EISSN: 18380212     Source Type: Journal    
DOI: None     Document Type: Article

References (128)

1. Lindstedt G, Tryding N. [There is difference between decision limits and reference intervals.Reference intervals are based on measurements in healthy individuals, decision limits on measurements in patients]. Lakartidningen 2007;104:2076-9.
2. Sikaris K. Application of the stockholm hierarchy to defining the quality of reference intervals and clinical decision limits. Clin Biochem Rev 2012;33:141-8.
3. Petersen PH, Jensen EA, Brandslund I. Analytical performance, reference values and decision limits. A need to differentiate between reference intervals and decision limits and to define analytical quality specifications. Clin Chem Lab Med 2012;50:819-31.
4. Boyd JC. Defining laboratory reference values and decision limits: populations, intervals, and interpretations. Asian J Androl 2010;12:83-90.
5. Ceriotti F, Henny J. Are my laboratory results normal? Considerations to be made concerning reference intervals and decision limits. eJIFCC 2008;19:1-9.
6. International Organization for Standardization (ISO). Medical Laboratories - Particular Requirements for Quality and Competence. ISO 15189. Geneva: ISO; 2012.
7. Xin Z, Yuan MX, Li HX, Hua L, Feng JP, Shi J, et al. Evaluation for fasting and 2-hour glucose and HbAlc for diagnosing diabetes based on prevalence of retinopathy in a Chinese population. PLoS One 2012;7:e40610.
8. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, et al. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 2000;23:1113-8.
9. Cho NH, Kim TH, Woo SJ, Park KH, Lim S, Cho YM, et al. Optimal HbA1c cutoff for detecting diabetic retinopathy. Acta Diabetol 2013;50:837-42.
10. Cheng YJ, Gregg EW, Geiss LS, Imperatore G, Williams DE, Zhang X, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care 2009;32:2027-32.
11. Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008;371:736-43.
12. Jonas JB, Xu L, Xie XW, Wang YX. Relationship between fasting glucose and retinopathy for diagnosis of diabetes: results from a population-based study in urban and rural China. Retina 2010;30:1223-7.
13. Clinical and Laboratory Standards Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory; Approved guideline - Third Edition. CLSI Document C28-A3. Wayne, PA, USA:CLSI; 2008.
14. Saris NE. The International Federation of Clinical Chemistry, IFCC Section (1978) n. 2. International Federation of Clinical Chemistry provisional recommendation on the theory of reference values (1978). Part 1. The concept of reference values. J Clin Chem Clin Biochem 1979;17:337-9.
15. PetitClerc C, Wilding P. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Sectio. The theory of reference values. Part 2. Selection of individuals for the production of reference values. J Clin Chem Clin Biochem 1984;22:203-8.
16. Solberg HE, PetitClerc C. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Value. Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values. J Clin Chem Clin Biochem 1988;26:593-8.
17. Solberg HE, Stamm D. International Federation of Clinical Chemistry IFCC.IFCC recommendation- theory of reference values.Part 4.Control of analytical variation in the production, transfer and application of reverence values. Clin Chim Acta 1991;202:S5-11.
18. International Federation of Clinical Chemistry, Scientific Committee, Clinical Section. Expert Panel on Theory of Reference Values (EPTRV. The theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. Clin Chim Acta 1984;137:97F-114F.
19. Dybkaer R. International federation of clinical chemistry (IFCC)1),2) the theory of reference value. Part 6. Presentation of observed values related to reference values. J Clin Chem Clin Biochem 1982;20:841-5.
20. Solberg HE. A guide to IFCC recommendations on reference values. J Int Fed Clin Chem 1993;5:162-5.
21. Harris EK. Statistical aspects of reference values in clinical pathology. Prog Clin Pathol 1981;8:45-66.
22. Van Steirteghem AC, Robertson EA, Young DS. Variance components of serum constituents in healthy individuals. Clin Chem 1978;24:212-22.
23. Jiménez CV Usefulness of reference limits and evaluation of significant differences. An example of the biological variation of serum rheumatoid factors. Ann Biol Clin (Paris) 1994;52:529-33.
24. Iglesias N, Petersen PH, Ricös C. Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality. Clin Chem Lab Med 2005;43:441-8.
25. Andersen TB, Erlandsen EJ, Frokiaer J, Eskild-Jensen A, Brochner-Mortensen J. Comparison of within- and between-subject variation of serum cystatin C and serum creatinine in children aged 2-13 years. Scand J Clin Lab Invest 2010;70:54-9.
26. Harris EK. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974;20:1535-42.
27. Petersen PH, Sandberg S, Fraser CG, Goldschmidt H. Influence of index of individuality on false positives in repeated sampling from healthy individuals. Clin Chem Lab Med 2001;39:160-5.
28. Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004;42:758-64.
29. Carlsson L, Lind L, Larsson A. Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology 2010;56:259-65.
30. Lubke S, Sikaris KA, Kanowski D, Flatman R, Norman P, Badrick T. Validation of electrolyte reference intervals. Clin Biochem Rev 2005;26(Suppl):S28.
31. Sikaris KA, Kanowski D, Caldwell G, Sack S, Flatman R. Consensus network reference intervals. Clin Biochem Rev 2006;27(Suppl):S34.
32. Sikaris KA, Lu Z, Kanowski D, Price L, Flatman R, Caldwell G, et al. Defining Sonic Network reference intervals for pregnancy. Clin Biochem Rev 2009;30(Suppl):S20.
33. Sikaris KA, Lu Z, Kanowski D, Price L, Flatman R, Caldwell G, et al. Defining Sonic Network reference intervals for children. Clin Biochem Rev 2009;30(Suppl):S20.
34. Rowbotham B, Maxwell E, Sikaris KA. Indirect estimation of haematology reference intervals by data mining. Int J Lab Hematol 2010;32(s1):138.
35. Grinspon RP, Rey RA. New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a Sertoli cell marker. Arq Bras Endocrinol Metabol 2011;55:512-9.
36. Josso N, Belville C, di Clemente N, Picard JY. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Hum Reprod Update 2005;11:351-6.
37. Shi L, Remer T, Buyken AE, Hartmann MF, Hoffmann P, Wudy SA. Prepubertal urinary estrogen excretion and its relationship with pubertal timing. Am J Physiol Endocrinol Metab 2010;299:E990-7.
38. Reiter EO, Root AW. Hormonal changes of adolescence. Med Clin North Am 1975;59:1289-304.
39. Porquet D. [Endocrine biochemistry of puberty]. Ann Biol Clin (Paris) 1997;55:425-33.
40. Richmond EJ, Rogol AD. Male pubertal development and the role of androgen therapy. Nat Clin Pract Endocrinol Metab 2007;3:338-44.
41. Hiort O. Androgens and puberty. Best Pract Res Clin Endocrinol Metab 2002;16:31-41.
42. Goldman J, Becker ML, Jones B, Clements M, Leeder JS. Development of biomarkers to optimize pediatric patient management: what makes children different?. Biomark Med 2011;5:781-94.
43. Cole TJ. Assessment of growth. Best Pract Res Clin Endocrinol Metab 2002;16:383-98.
44. Mora S, Cafarelli L, Erba P, Puzzovio M, Zamproni I, Giacomet V, et al. Differential effect of age, gender and puberty on bone formation rate assessed by measurement of bone-specific alkaline phosphatase in healthy Italian children and adolescents. J Bone Miner Metab 2009;27:721-6.
45. Shine B. Use of routine clinical laboratory data to define reference intervals. Ann Clin Biochem 2008;45:467-75.
46. Gajewska J, Ambroszkiewicz J, Laskowska-Klita T. [Some bone turnover markers in serum of healthy children and adolescents in relation to age and gender]. Wiad Lek 2005;58:476-80.
47. Soliman A, De Sanctis V, Adel A, El Awwa A, Bedair S. Clinical, biochemical and radiological manifestations of severe vitamin d deficiency in adolescents versus children: response to therapy. Georgian Med News 2012;210:58-64.
48. Kovar I, Mayne P, Barltrop D. Plasma alkaline phosphatase activity: a screening test for rickets in preterm neonates. Lancet 1982;1:308-10.
49. Ohata Y, Ozono K. [Updates on rickets and osteomalacia: guidelines for diagnosis of rickets and osteomalacia]. Clin Calcium 2013;23:1421-8.
50. Round JM. Plasma calcium, magnesium, phosphorus, and alkaline phosphatase levels in normal British schoolchildren. Br Med J 1973;3:137-40.
51. Boer DP, de Rijke YB, Hop WC, Cransberg K, Dorresteijn EM. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol 2010;25:2107-13.
52. Finney H, Newman DJ, Thakkar H, Fell JM, Price CP. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 2000;82:71-5.
53. Jopling J, Henry E, Wiedmeier SE, Christensen RD. Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system. Pediatrics 2009;123:e333-7.
54. Dapper DV, Nwauche CA, Siminialayi IM. Some haematological reference values for pre-primary and primary school aged children in Port Harcourt, Nigeria. Niger J Clin Pract 2009;12:262-7.
55. Igarashi T, Itoh Y, Maeda M, Igarashi T, Fukunaga Y. Mean hemoglobin levels in venous blood samples and prevalence of anemia in Japanese elementary and junior high school students. J Nippon Med Sch 2012;79:232-5.
56. El-Hazmi MA, Warsy AS. Normal reference values for hematological parameters, red cell indices, HB A2 and HB F from early childhood through adolescence in Saudis. Ann Saudi Med 2001;21:165-9.
57. Wallis LA, Healy M, Undy MB, Maconochie I. Age related reference ranges for respiration rate and heart rate from 4 to 16 years. Arch Dis Child 2005;90:1117-21.
58. Fleming S, Thompson M, Stevens R, Heneghan C, Plüddemann A, Maconochie I, et al. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet 2011;377:1011-8.
59. Greeley C, Snell J, Colaco, Beatey J, Bailey J, Bjorn S, et al. Paediatric reference ranges for electrolytes and creatinine. Clin Chem 1993;39:1172.
60. Ghoshal AK, Soldin SJ. Evaluation of the Dade Behring Dimension RxL: integrated chemistry system-pediatric reference ranges. Clin Chim Acta 2003;331:135-46.
61. Chan MK, Seiden-Long I, Aytekin M, Quinn F, Ravalico T, Ambruster D, et al. Canadian Laboratory Initiative on Pediatric Reference Interval Database (CALIPER): pediatric reference intervals for an integrated clinical chemistry and immunoassay analyzer, Abbott ARCHITECT ci8200. Clin Biochem 2009;42:885-91.
62. Pianosi P, Wolstein R. Carbon dioxide chemosensitivity and exercise ventilation in healthy children and in children with cystic fibrosis. Pediatr Res 1996;40:508-13.
63. Cassels DE, Morse M. Arterial blood gases and acid-base balance in normal children. J Clin Invest 1953;32:824-36.
64. Dong SH, Liu HM, Song GW, Rong ZP, Wu YP. Arterialized capillary blood gases and acid-base studies in normal individuals from 29 days to 24 years of age. Am J Dis Child 1985;139:1019-22.
65. Burritt MF, Slockbower JM, Forsman RW, Offord KP, Bergstralh EJ, Smithson WA. Pediatric reference intervals for 19 biologic variables in healthy children. Mayo Clin Proc 1990;65:329-36.
66. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854-68.
67. Burritt MF, Slockbower JM, Forsman RW, Offord KP, Bergstralh EJ, Smithson WA. Pediatric reference intervals for 19 biologic variables in healthy children. Mayo Clin Proc 1990;65:329-36.
68. Henning SJ. Biochemistry of intestinal development. Environ Health Perspect 1979;33:9-16.
69. Patel MS, Srinivasan M. Metabolic programming in the immediate postnatal life. Ann Nutr Metab 2011;58(Suppl 2):18-28.
70. Aggarwal J, Swami G, Kumar M. Probiotics and their Effects on Metabolic Diseases: An Update. J Clin Diagn Res 2013;7:173-7.
71. Hicks JM, Bjorn S, Beatey J, et al. Pediatric reference ranges for albumin, globulin and total protein on the Hitachi 747. Clin Chem 1995;41:S93.
72. Falcäo RP. Human blood lymphocyte subpopulations from birth to eight years. Clin Exp Immunol 1980;39:203-7.
73. Belldegrin A, Shoenfeld Y, Pick AI, Vana D. Age related distribution of serum immunoglobulin concentration in 1003 healthy children and adults. Biomedicine 1980;33:8-12.
74. Cheek DB, Petrucco OM, Gillespie A, Ness D, Green RC. Muscle cell growth and the distribution of water and electrolyte in human pregnancy. Early Hum Dev 1985;11:293-305.
75. Winston J, Levitt MF. Renal function, renal disease and pregnancy. In: Cherry SH, Merkatz IR, Editors: Complications of Pregnancy: Medical, Surgical, Gynecologic, Psychosocial and Perinatal. 4th ed. Baltimore: Williams & Wilkins; 1991. p. 502.
76. Horton DK, Adetona O, Aguilar-Villalobos M, Cassidy BE, Pfeiffer CM, Schleicher RL, et al. Changes in the concentrations of biochemical indicators of diet and nutritional status of pregnant women across pregnancy trimesters in Trujillo, Peru, 2004-2005. Nutr J 2013;12:80.
77. Valenzuela GJ, Munson LA, Tarbaux NM, Farley JR. Time-dependent changes in bone, placental, intestinal, and hepatic alkaline phosphatase activities in serum during human pregnancy. Clin Chem 1987;33:1801-6.
78. Bacq Y, Zarka O, Brechot JF, Mariotte N, Vol S, Tichet J, et al. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996;23:1030-4.
79. Ekinci E, Lu ZX, Sikaris KA, Atanasovski D, Bittar I, Lam Q, et al. Alkaline phosphatase reference intervals in pregnancy. Clin Biochem Rev 2012;33:S23.
80. Kristensen K, Larsson I, Hansson SR. Increased cystatin C expression in the pre-eclamptic placenta. Mol Hum Reprod 2007;13:189-95.
81. Wu Y, Xiong X, Fraser WD, Luo ZC. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies. Am J Hypertens 2012;25:711-7.
82. Nwagha UI, Ejezie FE, Iyare EE. Evaluation of serum uric acid levels in normal pregnant Nigerian women. Niger J Clin Pract 2009;12:83-6.
83. Klsstrup E, Trydal T, Pedersen JF, Larsen JM, Lundbye-Christensen S, Kristensen SR. Reference intervals and age and gender dependency for arterial blood gases and electrolytes in adults. Clin Chem Lab Med 2011;49:1495-500.
84. Jensen D, Duffin J, Lam YM, Webb KA, Simpson JA, Davies GA, et al. Physiological mechanisms of hyperventilation during human pregnancy. Respir Physiol Neurobiol 2008;161:76-86.
85. Weissgerber TL, Wolfe LA, Hopkins WG, Davies GA. Serial respiratory adaptations and an alternate hypothesis of respiratory control in human pregnancy. Respir Physiol Neurobiol 2006;153:39-53.
86. Hadziomerovic D, Moeller KT, Licht P, Hein A, Veitenhansel S, Kusmitsch M, et al. The biphasic pattern of end-expiratory carbon dioxide pressure: a method for identification of the fertile phase of the menstrual cycle. Fertil Steril 2008;90:731-6.
87. Kastrup A, Dichgans J, Niemeier M, Schabet M. Changes of cerebrovascular CO2 reactivity during normal aging. Stroke 1998;29:1311-4.
88. Preston ME, Jensen D, Janssen I, Fisher JT. Effect of menopause on the chemical control of breathing and its relationship with acid-base status. Am J Physiol Regul Integr Comp Physiol 2009;296:R722-7.
89. Orr-Walker BJ, Horne AM, Evans MC, Grey AB, Murray MA, McNeil AR, et al. Hormone replacement therapy causes a respiratory alkalosis in normal postmenopausal women. J Clin Endocrinol Metab 1999;84:1997-2001.
90. Nordin BE, Need AG, Hartley TF, Philcox JC, Wilcox M, Thomas DW. Improved method for calculating calcium fractions in plasma: reference values and effect of menopause. Clin Chem 1989;35:14-7.
91. Nordin BE, Need AG, Morris HA, Horowitz M. Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses. Osteoporos Int 1999;9:351-7.
92. Nordin BE, Need AG, Morris HA, O'Loughlin PD, Horowitz M. Effect of age on calcium absorption in postmenopausal women. Am J Clin Nutr 2004;80:998-1002.
93. Nordin BE, Horowitz M, Need A, Morris HA. Renal leak of calcium in post-menopausal osteoporosis. Clin Endocrinol (Oxf) 1994;41:41-5.
94. Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G, et al. Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 2003;149:209-13.
95. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006;166:1380-8.
96. Maggio M, Ceda GP, Lauretani F, Bandinelli S, Metter EJ, Guralnik JM, et al. Gonadal status and physical performance in older men. Aging Male 2011;14:42-7.
97. Harm K. [Reference ranges in geriatrics: a review of age dependence of selected blood components.]. Z Gerontol Geriatr 1997;30:185-92.
98. Goto M. Inflammaging (inflammation + aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory?. Biosci Trends 2008;2:218-30.
99. Xi H, Li C, Ren F, Zhang H, Zhang L. Telomere, aging and age-related diseases. Aging Clin Exp Res 2013;25:139-46.
100. Merksamer PI, Liu Y, He W, Hirschey MD, Chen D, Verdin E. The sirtuins, oxidative stress and aging: an emerging link. Aging (Albany NY) 2013;5:144-50.
101. Barzilai N, Gabriely I, Atzmon G, Suh Y, Rothenberg D, Bergman A. Genetic studies reveal the role of the endocrine and metabolic systems in aging. J Clin Endocrinol Metab 2010;95:4493-500.
102. Bonneux L, Barendregt JJ, Van der Maas PJ. The expiry date of man: a synthesis of evolutionary biology and public health. J Epidemiol Community Health 1998;52:619-23.
103. Ruivo S, Viana P, Martins C, Baeta C. Effects of aging on lung function. A comparison of lung function in healthy adults and the elderly. Rev Port Pneumol 2009;15:629-53.
104. Ren WY, Li L, Zhao RY, Zhu L. Age-associated changes in pulmonary function: a comparison of pulmonary function parameters in healthy young adults and the elderly living in Shanghai. Chin Med J (Engl) 2012;125:3064-8.
105. Vaz Fragoso CA, Lee PJ. The aging lung. J Gerontol A Biol Sci Med Sci 2012;67:233-5.
106. Rule AD, Cornell LD, Poggio ED. Senile nephrosclerosis--does it explain the decline in glomerular filtration rate with aging?. Nephron Physiol 2011;119(Suppl 1):6-11.
107. Christensson A, Elmstahl S. Estimation of the age-dependent decline of glomerular filtration rate from formulas based on creatinine and cystatin C in the general elderly population. Nephron Clin Pract 2011;117:c40-50.
108. Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc 2009;120:419-28.
109. Giannoni A, Giovannini S, Clerico A. Measurement of circulating concentrations of troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?. Clin Chem Lab Med 2009;47:1167-77.
110. Bima A, Lu ZX, Botros M, Sikaris KA. Age and eGFR as predictors of high sensitivity Troponin T. Clin Biochem Rev 2011;32(Suppl):S37.
111. Bima A, Sikaris K. Towards appreciating appropriate clinical responses to highly sensitive cardiac troponin assays. Intern Med J 2012;42(Suppl 5):16-22.
112. Vasikaran SD, MacDonald SP, Sikaris KA. High sensitivity cardiac troponin assays for risk stratification and for the diagnosis of acute myocardial. Ann Clin Biochem 2012;49:209-10.
113. Vasikaran SD, Bima A, Botros M, Sikaris KA. Comment on: Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays--an update from the Canadian society of clinical chemists (CSCC); the case for age related acute myocardial infarction (AMI) cut-offs. Clin Biochem 2012;45:513-4.
114. Huber KR, Mostafaie N, Stangl G, Worofka B, Kittl E, Hofmann J, et al. Clinical chemistry reference values for 75-year old apparently healthy persons. Clin Chem Lab Med 2006;44:1355-60.
115. Plebani M, Lippi G. Personalized (laboratory) medicine: a bridge to the future. Clin Chem Lab Med 2013;51:703-6.
116. Lahti A. Partitioning biochemical reference data into subgroups: comparison of existing methods. Clin Chem Lab Med 2004;42:725-33.
117. Kenny D, Fraser CG, Hyltoft Petersen P, Kallner A. Consensus Agreement: Conference on strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999;59:585.
118. Sikaris K. Application of the stockholm hierarchy to defining the quality of reference intervals and clinical decision limits. Clin Biochem Rev 2012;33:141-8.
119. Stinton TJ, Cowley DM, Bryant SJ. Reference intervals for calcium, phosphate, and alkaline phosphatase as derived on the basis of multichannel-analyzer profiles. Clin Chem 1986;32:76-9.
120. Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990;36:265-70.
121. Ichihara K, Kawai T. Determination of reference intervals for 13 plasma proteins based on IFCC international reference preparation (CRM470) and NCCLS proposed guideline (C28-P, 1992): a strategy for partitioning reference individuals with validation based on multivariate analysis. J Clin Lab Anal 1997;11:117-24.
122. Shaw JL, Binesh Marvasti T, Colantonio D, Adeli K. Pediatric reference intervals: challenges and recent initiatives. Crit Rev Clin Lab Sci 2013;50:37-50.
123. Shine B. Use of routine clinical laboratory data to define reference intervals. Ann Clin Biochem 2008;45:467-75.
124. Bock BJ, Dolan CT, Miller GC, Fitter WF, Hartsell BD, Crowson AN, et al. The data warehouse as a foundation for population-based reference intervals. Am J Clin Pathol 2003;120:662-70.
125. Henny J. The IFCC recommendations for determining reference intervals: strengths and limitations. J Lab Med 2009;33:45-51.
126. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results: is there a better way?. Am J Clin Pathol 2010;133:180-6.
127. Kanno T, Ohgushi Y, Shibata T. Setting reference intervals without considering sex and age differences. Rinsho Byori 2008;56:622-6.
128. Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004;42:758-64.